In ₹ Crore except Per Share 12 Months Ending | Q2 FY24 30/09/2023 | Q3 FY24 31/12/2023 | Q4 FY24 31/03/2024 | Q1 FY25 30/06/2024 | Q2 FY25 30/09/2024 | Q3 FY25 31/12/2024 | Q4 FY25 31/03/2025 | Q1 FY26 30/06/2025 | Q2 FY26 30/09/2025 | Q3 FY26 31/12/2025 | Q4 FY26 31/03/2026 | Q1 FY27 30/06/2026 | |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Revenue from Operations | 30.2 | 31.7 | 36.1 | 33.8 | 36.1 | 38.9 | 42.8 | 41.7 | 89.5 | 50.4 | 57.2 | 54.0 | |
| Other Income | 1.0 | 0.5 | 0.4 | 0.2 | 0.8 | 1.3 | 0.7 | 1.0 | 1.6 | 0.8 | 0.1 | 0.1 | |
| Total Income | 31.2 | 32.2 | 36.6 | 34.0 | 36.8 | 40.2 | 43.5 | 42.7 | 91.1 | 51.2 | 57.3 | 54.0 | |
| Expenses | |||||||||||||
| + Employee Benefit Expense | 6.7 | 7.0 | 7.6 | 8.1 | 8.7 | 9.7 | 11.0 | 11.6 | 24.3 | 12.7 | 13.5 | 14.1 | |
| + Finance Costs | 13.1 | 13.1 | 13.7 | 14.0 | 14.9 | 16.5 | 16.6 | 16.8 | 34.9 | 20.1 | 22.7 | 23.9 | |
| + Depreciation & Amortisation | 1.3 | 1.6 | 1.7 | 1.5 | 1.6 | 1.7 | 1.8 | 1.4 | 2.9 | 1.5 | 1.4 | 1.2 | |
| + Other Expenses | 3.3 | 3.6 | 5.5 | 3.4 | 3.9 | 4.1 | 5.4 | 4.5 | 9.7 | 5.7 | 6.8 | 4.7 | |
| Total Expenses | 24.6 | 25.5 | 28.9 | 27.1 | 28.5 | 33.1 | 35.8 | 34.8 | 73.0 | 40.9 | 45.7 | 44.0 | |
| EBITDA | 20.0 | 20.9 | 22.6 | 22.2 | 24.1 | 24.1 | 25.3 | 25.1 | 54.3 | 31.2 | 35.6 | 35.1 | |
| EBIT | 18.7 | 19.3 | 20.9 | 20.7 | 22.5 | 22.4 | 23.5 | 23.6 | 51.4 | 29.7 | 34.2 | 33.8 | |
| Profit | |||||||||||||
| PBT before Exceptional Items | 6.6 | 6.7 | 7.6 | 6.9 | 8.3 | 7.2 | 7.7 | 7.8 | 18.2 | 10.4 | 11.6 | 10.0 | |
| Pretax Income | 6.6 | 6.7 | 7.6 | 6.9 | 8.3 | 7.2 | 7.7 | 7.8 | 18.2 | 10.4 | 11.6 | 10.0 | |
| + Current Tax | 1.4 | 1.6 | 2.0 | 1.2 | 1.9 | 1.8 | 1.8 | 1.5 | 3.9 | 2.6 | 2.9 | 1.8 | |
| + Deferred Tax | -0.1 | -0.2 | -0.5 | -0.2 | -0.1 | -0.4 | -0.3 | -0.4 | -0.8 | -0.4 | -0.6 | -0.2 | |
| Tax Expense | 1.3 | 1.4 | 1.5 | 1.0 | 1.7 | 1.4 | 1.5 | 1.1 | 3.1 | 2.2 | 2.3 | 1.5 | |
| Net Income | 5.3 | 5.3 | 6.1 | 5.9 | 6.6 | 5.7 | 6.2 | 6.8 | 15.0 | 8.2 | 9.2 | 8.5 | |
| + Net Income — Continuing Ops | 5.3 | 5.3 | 6.1 | 5.9 | 6.6 | 5.7 | 6.2 | 6.8 | 15.0 | 8.2 | 9.2 | 8.5 | |
| + Other Comprehensive Income | 0.1 | 0.0 | -0.1 | 0.0 | 0.4 | -0.4 | -0.1 | 0.0 | -0.0 | -0.0 | 0.1 | 0.0 | |
| Total Comprehensive Income | 5.4 | 5.3 | 6.0 | 5.9 | 7.0 | 5.4 | 6.1 | 6.8 | 15.0 | 8.2 | 9.3 | 8.5 | |
| Per Share | |||||||||||||
| Basic EPS | 4.05 | 4.09 | 4.58 | 4.38 | 4.87 | 4.16 | 4.43 | 4.33 | 9.59 | 5.23 | 5.89 | 5.39 | |
| Diluted EPS | 3.90 | 3.94 | 4.51 | 4.34 | 4.62 | 4.16 | 4.43 | 4.32 | 9.58 | 5.23 | 5.89 | 5.39 | |
| Revenue Detail — as filed | |||||||||||||
| + Fees & Commission Income | 1.4 | 1.1 | 2.5 | 0.8 | — | 3.3 | 3.0 | 1.9 | 5.2 | 3.1 | 4.3 | 1.0 | |
| + Net Gain on Fair Value Changes | 0.0 | 0.2 | 0.0 | 0.0 | — | 0.0 | 0.0 | 0.0 | 0.0 | 0.1 | 0.0 | 0.2 | |
| + Net Loss on Fair Value Changes | 0.0 | 0.0 | 0.2 | 0.0 | — | 0.0 | 0.0 | 0.0 | 0.0 | 0.0 | 0.1 | 0.0 | |
| + Net Gain on Derecognition — Amortised Cost | 0.0 | 0.0 | 0.0 | 0.0 | — | 0.0 | 0.1 | 0.1 | 0.3 | 0.0 | 0.2 | 0.2 | |
| Expense Detail — as filed | |||||||||||||
| + Impairment on Financial Instruments | 0.2 | 0.3 | 0.2 | 0.1 | — | 1.0 | 1.1 | 0.6 | 1.1 | 0.8 | 1.2 | 0.1 | |
| Other Comprehensive Income — detail | |||||||||||||
| + Other Comprehensive Income | 0.1 | 0.0 | -0.1 | 0.0 | — | -0.4 | -0.1 | 0.0 | -0.0 | -0.0 | 0.1 | 0.0 | |
| + Items NOT to be Reclassified to P&L | 0.1 | 0.0 | -0.2 | 0.0 | — | -0.5 | -0.1 | 0.0 | -0.0 | -0.0 | 0.1 | 0.0 | |
| + Tax on Items NOT to be Reclassified | — | — | — | — | — | — | -0.0 | 0.0 | -0.0 | -0.0 | 0.0 | 0.0 | |
| + Tax on Items NOT to be Reclassified — alt tag | 0.0 | 0.0 | -0.0 | 0.0 | — | -0.1 | — | — | — | — | — | — | |
| Per Share — as-filed variants | |||||||||||||
| Basic EPS — Continuing Operations | 4.05 | 4.09 | 4.58 | 4.38 | 4.87 | 4.16 | 4.43 | 4.33 | 9.59 | 5.23 | 5.89 | 5.39 | |
| Diluted EPS — Continuing Operations | 3.90 | 3.94 | 4.51 | 4.34 | 4.62 | 4.16 | 4.43 | 4.32 | 9.58 | 5.23 | 5.89 | 5.39 | |
| Regulatory Disclosures — filed alongside, not part of the P&L | |||||||||||||
| Related-party Transactions — During the Period | — | — | — | — | — | — | 3.3 | — | 3.5 | — | 9.8 | — | |
| Derived — Gross Profit (Revenue − Materials − Purchases − Δ Inventories) | |||||||||||||
| Gross Profit | 30.2 | 31.7 | 36.1 | 33.8 | 36.1 | 38.9 | 42.8 | 41.7 | 89.5 | 50.4 | 57.2 | 54.0 | |
| Gross Margin % | 100.00 | 100.00 | 100.00 | 100.00 | 100.00 | 100.00 | 100.00 | 100.00 | 100.00 | 100.00 | 100.00 | 100.00 | |
| Adjusted (ex-Exceptional Items) — derived | |||||||||||||
| Pretax Income (Adjusted, as filed) | 6.6 | 6.7 | 7.6 | 6.9 | 8.3 | 7.2 | 7.7 | 7.8 | 18.2 | 10.4 | 11.6 | 10.0 | |
| Net Income Adj (tax-effected) | 5.3 | 5.3 | 6.1 | 5.9 | 6.6 | 5.7 | 6.2 | 6.8 | 15.0 | 8.2 | 9.2 | 8.5 | |
| EPS Adj | 4.05 | 4.09 | 4.58 | 4.38 | 4.87 | 4.16 | 4.43 | 4.33 | 9.59 | 5.23 | 5.89 | 5.39 | |
| Other Filed Concepts — mapped but not yet placed in the schedule | |||||||||||||
| Face Value | 10.00 | 10.00 | 10.00 | 10.00 | 10.00 | 10.00 | 10.00 | 10.00 | 10.00 | 24,827.36 | 10.00 | 10.00 | |
| Filed Debt Equity | 0.03 | 0.03 | 0.03 | 0.03 | 0.03 | 0.03 | 0.02 | 0.02 | 0.02 | 0.03 | 0.03 | 0.03 | |
| Filed Dscr | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.01 | 0.00 | 0.01 | 0.01 | 0.01 | 0.01 | 0.01 | |
| Filed Iscr | 0.02 | 0.02 | 0.02 | 0.01 | 0.02 | 0.01 | 0.01 | 0.01 | 0.02 | 0.02 | 0.02 | 0.01 | |
| Interest Earned | 26.6 | 28.3 | 30.0 | 31.0 | — | 33.7 | 37.0 | 37.1 | 78.6 | 44.3 | 50.7 | 50.9 | |
| Paid Up Equity Capital | 13.0 | 13.0 | 13.3 | 13.5 | 14.3 | 14.3 | 15.7 | 15.7 | 15.7 | 15.7 | 15.7 | 15.7 | |